24 results on '"Krämer, Alwin"'
Search Results
2. Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid Leukemia
3. Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary
4. Micronucleus formation in human cancer cells is biased by chromosome size
5. Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome
6. Micronucleus formation in human cancer cells is biased by chromosome size
7. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia
8. CD7 is expressed on a subset of normal CD34-positive myeloid precursors
9. Phase I dose‐escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia
10. Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients
11. Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial
12. Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort
13. Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts-a retrospective single-center experience
14. A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia
15. Centrosome clustering and chromosomal (in)stability: A matter of life and death
16. Antiapoptotic function of charged multivesicular body protein 5: A potentially relevant gene in acute myeloid leukemia
17. Increased levels of 2‐hydroxyglutarate in AML patients with IDH1‐R132H and IDH2‐R140Q mutations
18. Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group
19. Expression of centrosome‐associated gene products is linked to tetraploidization in mantle cell lymphoma
20. High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia
21. Centrosome aberrations in hematological malignancies
22. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression
23. Regulation of cyclins by adhesion: Elements in the anchorage‐signalling pathway
24. Palbociclib in Acute Leukemias With KMT2A -rearrangement: Results of AMLSG 23-14 Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.